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We demonstrate in this study that both TIMP-1 and TIMP-2 are major serum factors that stimulate the induction of TIMP-1 mRNA in
quiescent human gingival fibroblasts (Gin-1 cells) at mid-G1 (6–9 h after serum stimulation) of the cell cycle, but not that of TIMP-2. When we
chased the secretion of both TIMP proteins into culture medium containing 10% FCS freed of both TIMPs, TIMP-2 secretion rose to the level in
10% FCS after 24 h, but TIMP-1 secretion remained at a fairly low level even after 3 days, thus reflecting a contrastive difference in the induction
of both TIMP mRNAs. The stimulating activity of TIMP-1 on the expression of the TIMP-1 gene switched over to inhibitory activity, when the
TIMP-1 concentration in the culture medium exceeded about 30 ng/ml. The depletion of TIMP-1 and TIMP-2 from FCS affected remarkably the
induction of c-jun and c-fos mRNAs, but not that of c-ets-1 mRNA. TIMP-1 and TIMP-2-dependent expression of AP-1 protein was further
demonstrated by using nuclear extracts of Gin-1 cells in an electrophoretic mobility shift assay.
© 2006 Elsevier B.V. All rights reserved.Keywords: Tissue inhibitor of metalloproteinases-1 (TIMP-1); TIMP-2; c-jun, c-fos and c-ets-1 mRNAs; AP-1; Human gingival fibroblasts (Gin-1 cells)1. Introduction
Tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2,
TIMP-3, and TIMP-4) [1–4] are now recognized as a family of
intrinsic inhibitors of matrix metalloproteinases (MMPs). The
ability of these TIMPs to inhibit MMPs suggests that these
inhibitors play an important role in the regulation of MMP
activity, effectively controlling the breakdown of extracellular
matrix components involved in various kinds of important
biological phenomena and pathological events such as inflam-
mation and tumor invasion [5–8]. Recently, some TIMPs,
especially TIMP-3, was reported to have inhibitory activity⁎ Corresponding author. Tel.: +81 52 751 2561x1343; fax: +81 52 752 5988.
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doi:10.1016/j.bbamcr.2006.02.012against some members of the ADAM (a disintegrin and metallo-
proteinase) family [9–11] and its new member, ADAMTS (a
disintegrin and metalloproteinase with thrombospondin motifs)
[12,13].
In addition to their functions as MMP inhibitors, TIMP-1
and TIMP-2 are reported to have potent growth promoting
activity for a wide range of cells [1,4], and some other
findings support the proposition that both TIMP-1 and TIMP-
2 are previously unrecognized cell-growth factors in serum
[14,15]. The cell growth-promoting activity of both TIMP-1
and TIMP-2 appears to be a direct cellular effect mediated by
cell-surface receptors [15–18], and is independent of their
functions as MMP inhibitors [15,19]. We also demonstrated
that either TIMP-1 or TIMP-2 at the concentrations (20 ng/ml
for TIMP-1 and 1 ng/ml for TIMP-2) resulting in maximal
3H-thymidine incorporation activity induced tyrosine phos-
phorylation, activated MAP kinase, and stimulated DNA
synthesis in the absence of other exogenous growth factors
[20]. As a peculiar behavior of TIMPs, we recently found that
Fig. 1. Time course of the induction of TIMP-1, and TIMP-2 mRNAs in Gin-1
cells. Quiescent cells were stimulated by 10% FCS (a), TIMP-1 and -2(−) FCS
(b), or TIMP-1 and -2(−) FCS plus hrTIMP-1 and -2 (c) for the indicated
times. Each mRNA was analyzed by standard RT-PCR as described in
Materials and methods. GAPDH was used as the loading control. The amounts
of hrTIMP-1 and -2 added in experiment c were 9.8 and 12.0 ng/ml,
respectively, which were the same as those originally contained in 10% FCS
used in this experiment. After scanning the intensity of each band, the ratio of
each TIMP-2 band intensity to that of the corresponding GAPDH was
calculated. TIMP-2 showed a slight decreasing tendency especially after 12
and 24 h, only in experiment b.
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gingival fibroblasts (Gin-1 cells) in a cell cycle-dependent
manner [21,22].
The TIMP-1 gene is highly inducible at the transcriptional
level in response to phorbol esters and serum factors [23–
25], but the expression of the TIMP-2 gene is largely
constitutive [24,26]. Within the promoter of the TIMP-1 gene
reside AP-1 and PEA3 motifs for transcription factors of the
c-Jun/c-Fos and c-Ets families, respectively [23,25,27–30].
Mouse 16C8 [31] acts as a ‘serum-inducible’ (‘cell-division
cycle’) gene to cause the induction of TIMP-1 mRNA at the
mid-G1 phase of the cell cycle. However, the identity of the
serum factors that induce TIMP-1 gene has not been
elucidated.
The aim of this study was to identify serum factors inducing
expression of the TIMP-1 gene. We found that both TIMP-1 and
TIMP-2 in serum are major serum factors that play important
roles in inducing the TIMP-1 gene and causing secretion of
TIMP-1 protein from Gin-1 cells.
2. Materials and methods
2.1. Materials
Materials and their sources were as follow: Dulbecco's modified Eagle's
medium (DMEM) and fetal calf serum (FCS) from Gibco Laboratories
(Grand Island, NY); actinomycin D (AD) and puromycin (PM) from Sigma
Chemical Co. (St. Louis, MO); ISOGEN from NPG Inc.(Toyama, Japan);
DNase I, dNTP mixture, and recombinant Taq DNA polymerase from
Takara Shuzo Co., Ltd. (Otsu, Shiga, Japan); oligo dT12–18 primer from
Pharmacia Biotech (Uppsala, Sweden); M-MLV reverse transcriptase from
GibcoBRL (Grand Island, NY); human gingival fibroblasts (Gin-1 cells;
HGF-1; CRL-2014) from the American Type Culture Collection (Rockville,
MD).
Human (hr) and bovine (br) recombinant TIMP-1s were expressed
in CHO cells by the same system used to express hrTIMP-2 [32], and
these rTIMP-1 and -2 were purified by the method detailed earlier
[15].
TIMP-1- and/or TIMP-2-free FCS was prepared by the passage of FCS
through anti-TIMP-1 [33] and anti-TIMP-2 [34] monoclonal antibody-
Sepharose 4B affinity columns or just one of these columns to remove TIMP-
1 and TIMP-2 or just one of them, respectively, and then sterilized by passage
through a Falcon 7105 bottle-top filter (0.22 μm). TIMP removal was confirmed
by one-step sandwich enzyme immunoassays (EIAs) for TIMP-1 [35] and
TIMP-2 [34]. These sera were designated as TIMP-1 and -2(−)FCS, TIMP-1(−)
FCS, and TIMP-2(−) FCS.
2.2. Cell culture
Gin-1 cells were grown to 40–70% confluence in D-MEM with 10%
FCS on 18-mm square cover-glass slips at 37 °C in 95% air and 5% CO2.
The cells were then washed 3 times with phosphate-buffered saline (PBS)
and maintained in serum-free DMEM for an additional 72 h. The quiescent
cells thus obtained were then transferred into medium containing 10% FCS,
TIMP-1(−)FCS, TIMP-2(−)FCS, TIMP-1 and -2(−)FCS, or TIMP-1 and -2
(−)FCS supplemented with rTIMP-1 and -2, and cultured for the desired
times.
2.3. RNA isolation and standard RT-PCR
Total RNA was isolated from Gin-1 cells with ISOGEN. Subsequent
chloroform extraction, RNA precipitation, and RNA washing were performed
according to the manufacturer's manual. About 20 μg of isolated total RNAwastreated with 10 U of DNase I at 37 °C for 60 min. The total RNA (2 μg) was
reverse transcribed to cDNA by use of oligo dT12–18 primer with M-MLV
reverse transcriptase for 60 min at 37 °C in the presence of 0.5 mM dNTPs.
The cDNAwas then amplified with each primer set using 0.63 U of recombinant
Taq DNA polymerase. The amplification conditions for TIMP-1, TIMP-2,
c-Jun, c-Fos, c-Ets-1, and GAPDH were as follow: 1 cycle of 94 °C for 3 min,
followed by 25 cycles (for c-Ets-1), 30 cycles (for TIMP-1, c-Fos, c-Jun
and GAPDH) and 40 cycles (for TIMP-2) of 15 second of denaturation at
94 °C, 30 s of annealing at 55 °C, and 30 s of extension at 72 °C in a
GeneAmp PCR System 2400 (Perkin Elmer, Branchberg, NJ). The
following primer pairs were used for RT-PCR amplification: TIMP-1 [36]
(528 bp): 5′-TTCGTGGGGACACCAGAAGTCAAC-3′ (198–221) and
5′-TGGACACTGTGCAGGCTTCAGTTC-3′ (725–702); TIMP-2 [37]
(568 bp): 5′-AAGCGGTCAGTGAGAAGGAGTGG-3′ (413–436) and 5′-
CCTTGGAGGCTTTTTTGCAGTTG-3′ (981–958); c-Jun [38] (315 bp):
5′-GGAAACGACCTTCTATGACGATGCCCTCAA-3′ (426–455); 5′ GAACCC-
CTCCTGCTCATCTGTCACGTTCTT-3′ (712–741); c-Fos [38] (442 bp): 5′-CTACGAGG-
CGTCATCCTCCCG-3′ (220–237) and 5′-TACGGCGTTGGCCTCCTCCCTQ
CGA-3′ (1178–1196); c-Ets-1 [39] (679 bp): 5′-AGCCGACTCTCACCAT-
CA-3′ (142–159); 5′-5′-TCTGCAAGGTGTCTGTCTGG-3′ (810–791);
GLYCERALDEHYDE-3-phosphate dehydrogenase (GAPDH) [40]
(452 bp): 5′-ACCACAGTCCATGCCATCAC-3′ (586–605) and 5′-TCCAC-
CACCCTGTTGCTGTA-3′ (1037–1018). The products of these reactions
were analyzed by electrophoresis on 2% agarose gels.
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The RNA competitors for determining the RNA of TIMP-1, TIMP-2, and
GAPDH by competitive RT-PCR were constructed by using a competitive RNA
construction kit and a competitive DNA transcription kit (TAKARA Biomedi-
cals) according to the manufacturer's instructions. The following primer pairs for
competitors were used for competitive RT-PCR amplification: TIMP-1 (448 bp):
5′-ATTTAGGTGACACTATAGAATACTTCGTGGGGA CACCAGAAGT-
CAA CGTACGGTCATCATCTGACAC-3′ and 5′-TGGACACTGTG-
CAGGCTTCAGTTCGCGTGAGTA TTACGAAGGTG-3′; TIMP-2 (442 bp):
5′-ATTTAGGTGACACTATAGAATACAAGCGGTCAG TGAGAAG-
GAGTGGGTACGGTCATCATCTGACAC-3 ′ and 5 ′ -CCTTGG-
AGGCTTTTTTGCAGTTGGCGTGAGTATT ACGAAGGTG-3′; GAPDH
(340 bp): 5′-ATTTAGGTGACACTATAGAATACACCACAGTCCATGCCAT-
CACGTACGGTCATCATCTGACAC-3′and 5′-TCCACCACCCTGTTGCTG-
TACGCCATCCTGGGAA GACTCC-3′.
2.5. Competitive RT-PCR
The competitive RT-PCR experiments were performed by the addition of an
increasing amount (5 step-wise dilution) of RNA competitor to the reverseFig. 2. Induction of TIMP-1 and TIMP-2 mRNAs in Gin-1 cells. The cells were cultu
plus h TIMP-1 and -2. Each mRNAwas analyzed by competitive RT-PCR as described
15 ng/ml, respectively, which were the same as those originally contained in 10
electrophoresis pattern. T and C denote target and competitor products, respective
correspond to copy numbers 5×101–5×108. Panel b, the band intensity of both target
Materials and methods, and the intensity was normalized against GAPDH to obtain
FCS.transcription reaction and PCR reaction. Both the target and competitor were co-
amplifiedwith the same set of primers that was used in the standard RT-PCR. The
initial amounts of the target mRNAwere determined by calculating howmuch of
the competitor was required to achieve equal molar amounts of products. The log
of the number of molecules of RNA competitor added to the sample before
starting amplification was plotted against the log of the ratio of molar amounts of
target and competitor. The lines were drawn from a linear regression analysis, and
the number of molecules of target message was calculated by extrapolating from
the intersection of the line where the molar ratio of target and competitor was
equal (log=0). The mRNA of TIMP-1, TIMP-2, and GAPDH in the same cDNA
sample was determined by competitive RT-PCR. GAPDH is a housekeeping
gene and reflects constitutive activity ubiquitous to eukaryotic cells. The amounts
of mRNA were expressed as a percentage of transcript relative to GAPDH in
order to correct the efficiency differences of total RNA extraction and reverse
transcription from RNA to DNA.
2.6. Agarose gel electrophoresis and determination of DNA band
intensities by image analysis
A portion of each PCR product was separated on 2% agarose gels at 50 V for
30 min in 1× TBE buffer (89 mM Tris-borate, 2 mM EDTA) and visualized byred for 6 h in 10% FCS, TIMP-1 and/or -2-free FCS, or TIMP-1 and -2(−) FCS
in Materials and methods. *The amounts of h TIMP-1 and -2 added were 12 and
% FCS used in this experiment. Panel a, each photo shows an agarose gel
ly. A–H correspond to copy numbers 101–108 of the competitor, and 5A–5E
(T) and competitor (C) products shown in panel a, were determined as detailed in
relative expression. Results are the mean±S.D. (n=3). **P<0.01 against 10%
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markers were subjected to electrophoresis for use as calibration standards for
determining the size or intensities of the PCR product bands. The gels were
photographed with a Polaroid MP-4 Land camera and type 667 film, scanned
and digitized on a Epson digital scanner, and stored as TIFF files. Band
intensities were determined 3 times by using the gel-plotting macro of NIH-
Image version 1.62 on a Macintosh computer, and then compared by statistical
analysis.
2.7. Oligonucleotides
The following 40-bp oligonucleotides containing AP-1 consensus se-
quences and their mutants were constructed: W, 5′-GGTGGGTGGAT-
GAGTAATGCATCCAGGAACCCTGGAGGCA-3′ and 5′-TGCCTCCA-
GGCTTCCTGGACGCATTACTCATCCACCCACC-3 ′ ; M , 5 ′ -
GGTGGGTGGAGGAGTGATGCGTCCAGGAAGCCTGGAGGCA-3′ and
5′-TGCCTCCAGGCTTCCTGGACGCATTACTCATCCACCCACC-3′. For
gel shift assays, each oligonucleotide was annealed and used as a probe.
2.8. Electrophoretic mobility shift assay
Nuclear extracts were prepared from 5×107 Gin-1 cells cultured under
different conditions by the method of Dignam et al. [41]. Extracts typically
contained 3 to 4 μg of protein/μl. All oligonucleotides were annealed in
equimolar amounts and end-labeled with T polynucleotide kinase and [γ-32P]
ATP followed by desalting through Sephadex G-25 spin columns. Binding
reaction mixtures (20 μl) contained 0.5 μg poly (dI-dC), 0.25 μg of Sau3A-
restricted pBluescript IIKS, 10 mM Tris–HCl (pH 7.5), 50 mM NaCl, 0.5 mM
DTT, 5 mM MgCl2, 2 mM EDTA, and 4% (v/v) glycerol along with 5 μg of
protein extract. Probes (1 ng) were added to this mixture, which was then
incubated on ice for 30min. Electrophoresis was carried out on low ionic strength
4% polyacrylamide gels at 4 °C as previously described [42]. The wet gels were
autoradiographed at −70 °C by using KodakXARS film and a single intensifying
screen.Fig. 3. Differential secretion of TIMP-1 and TIMP-2 by Gin-1 cells. The cells were c
confluence were first starved in FCS-free DMEM for 72 h, and then transferred into m
days. Both TIMP contents were determined in the culture media at the indicated days2.9. Determination of DNA concentration
DNA contents were determined by the method reported previously [43].
2.10. Statistical analysis
Inter group differences in mean values were statistically analyzed by use of
Student's t-test.3. Results and discussion
3.1. Expression of TIMP-1 and TIMP-2 genes by gin-1 cells
under different culture conditions
We confirmed that the expression of the TIMP-1 gene
reached peak levels at 6–9 h, which time corresponds to
around mid-G1 of the cell cycle, after FCS stimulation of
quiescent Gin-1 cells and that TIMP-2 gene expression was
constitutive (Fig. 1a). This time course was already reported
for mouse TIMP-1 [31]. We next looked at the effects of the
depletion of both TIMP-1 and TIMP-2 from FCS on the
mRNA level of both TIMPs. As shown in Fig. 1b, the
induction of TIMP-1 mRNA was completely suppressed by
the depletion of both TIMPs. The suppression was, however,
almost fully reversed by the addition of the same amounts of
both hrTIMPs as were present in the original 10% FCS (Fig.
1c). On the contrary, there was essentially no change in the
level of TIMP-2 mRNA by even depleting both TIMPs from
FCS, thus suggesting that both TIMPs in FCS stimulatedultured in 10% FCS or TIMP-1 and -2(−)FCS. Gin-1 cells that had reached 40%
edium containing 10% FCS [■] or TIMP-1 and -2(−)FCS [□] and cultured for 3
. Results are the mean±S.D. (n=4). *P<0.01 against the value of previous day.
Fig. 4. Effects of TIMP-1 concentration in culture medium on the expression
of TIMP-1 gene. The cells were cultured for 6 h in 10% FCS or 10% FCS plus
the indicated amounts of br TIMP-1. Each mRNA was analyzed by
competitive RT-PCR as described in Materials and methods. *The amount
of TIMP-1 originally contained in 10% FCS was 14 ng/ml. Abbreviations
used in panel a are the same as those in the legend for Fig. 2a. Results are the
mean±S.D. (n=3).
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known to be a housekeeping gene. To make a more precise
comparison of gene expression between the 2 TIMPs, we
conducted competitive RT-PCR studies on Gin-1 cells cultured
for 6 h under different conditions. The depletion of either
TIMP-1 or TIMP-2 alone from FCS caused a partial
suppression of the induction of TIMP-1 mRNA (Fig. 2).
The depletion of both TIMPs, however, led to almost full
suppression of TIMP-1 gene activation compared with that
attained with either TIMP alone. Again there was essentially
no change in the level of TIMP-2 mRNA under any culture
condition.
3.2. Effects of the depletion of TIMP-1 and TIMP-2 from FCS
on the differential secretion of TIMP-1 and TIMP-2 proteins
When we checked the amounts of both TIMPs secreted
into culture medium containing l0% FCS freed of both
TIMPs, we could see a contrastive difference in the secretion
profiles between TIMP-1 and TIMP-2, as shown in Fig. 3.
TIMP-2 secretion caught up to the level found in 10% FCS
already after 24 h on either a culture-medium volume basis
(Fig. 3b) or DNA weight basis (Fig. 3d), but TIMP-1
secretion remained at a fairly low level expressed on either a
culture-medium volume basis (Fig. 3a) or DNA weight basis
(Fig. 3c) even after 3 days. The contrastive difference in the
secretion profiles of TIMP-1 and TIMP-2 proteins in FCS
freed of both TIMPs is consistent with the induction profiles
of both TIMP mRNAs under the same conditions (Figs. 1
and 2).
3.3. Effects of TIMP-1 concentration in culture medium on the
expression of TIMP-1 gene
When TIMP-1 stimulates the expression of the TIMP-1
gene and secretion of its protein into a culture medium, it is
easily imagined that the TIMP-1 concentration in the medium
would increase continuously in an accelerated manner. To
check this point, we measured the TIMP-1 concentration in
the culture medium containing 10% FCS, and found that the
concentration leveled off after it reached about 30 ng/ml (Fig.
3a). As it is well known that each cell derived from a certain
species contains a constant amount of DNA [44], TIMP-1
content expressed on a DNA weight basis allowed us to read
relative the TIMP-1 amount expressed on a cell-number basis.
This content in the 10% FCS-containing cultures actually
decreased continuously day by day (Fig. 3c), thus suggesting
the presence of some suppression mechanism. To confirm this
point, we changed the TIMP-1 concentration in the culture
medium by adding rTIMP-1, and looked at the effects of the
TIMP-1 concentration in the medium on the induction of
TIMP-1 mRNA. When the TIMP-1 concentration in the
culture medium was increased from 24 ng/ml to 34 ng/ml, the
stimulating activity of TIMP-1 on the expression of the
TIMP-1 gene switched over to an inhibitory activity,
implying the presence of some concentration-dependent
switching mechanism (Fig. 4). In this particular experiment,we used brTIMP-1 instead of hrTIMP-1 for the preparation
of 10% FCS containing different concentrations of TIMP-1
to make the experiment as precise as possible. Experiments
are now under way in our laboratory to elucidate the
mechanism.
3.4. Effects of the depletion of TIMP-1 and TIMP-2 from FCS
on the induction of c-jun, c-fos, and c-ets-1 mRNAs
Within the promoter of the TIMP-1 gene, AP-1 and PEA3
motifs have been already identified as binding sites for the
transcription factors c-Jun/c-Fos and c-Ets family, respectively
[23,25,27–30]. We then confirmed whether the activation of
the TIMP-l gene by serum was mediated via the expression of
Fig. 6. Effects of the depletion of TIMP-1 and TIMP-2 from FCS on the
electrophoretic mobility shift assay of nuclear factors in Gin-1 cells. (a) 40-bp
region of the wild-type AP-1 consensus sequenced of the TIMP-1 gene promoter
(W) and that of its mutant form (M) [45]. (b) Electrophoretic mobility shift assay
of nuclear factors in Gin-1 cells binding to the 40-bp sequence. The double-
stranded wild-type and mutant 40-bp oligonucleotides were synthesized and
end-labeled (see Materials and methods). Probes were incubated with the
nuclear extract of Gin-1 cells, and then the formed complex was separated by
SDS-PAGE. The specific complex is indicated as “C.” Free probes are at the
bottom.
Fig. 5. Effects of the depletion of TIMP-1 and TIMP-2 from FCS on the induction of c-jun, c-fos, and c-ets-1 mRNAs in Gin-1 cells. Each mRNA was
analyzed by standard RT-PCR as described in Materials and methods. (a) Transcript levels at various times after addition of 10% FCS. (b) Cells were cultured
for 1 h for c-jun and c-fos, and for 30 min for c-ets-1 in the media indicated. 1, quiescent; 2, 10% FCS; 3, TIMP-1(−)FCS; 4, TIMP-2(−)FCS; 5, TIMP-1 and
-2(−)FCS; 6, same as 5 but with the addition of hrTIMP-1 (12 ng/ml) and -2 (15 ng/ml). The 10% FCS originally contained 12 ng/ml TIMP-1 and 15 ng/ml
TIMP-2.
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transcript levels of c-jun, c-fos and c-ets-1 after the addition
of 10% FCS, and found the maximal expression of c-jun and
c-fos after 1 h, and that of c-ets-1 after 30 min (Fig. 5a). As
shown in Fig. 5b, the induction of both c-jun and c-fos
mRNAs was partially suppressed by depleting TIMP-1 or
TIMP-2, and almost completely by depleting both TIMPs
from the FCS, thus suggesting that both TIMPs worked
synergistically. The suppression was, however, almost fully
reversed by the addition of both hrTIMPs. Earlier Yamashita
et al. [20] demonstrated that cell growth stimulation by either
TIMP-1 or TIMP-2 was mediated through tyrosine and
mitogen-activated protein (MAP) kinase in their intracellular
signaling. So, c-Jun and c-Fos would seem to act downstream
of MAP kinase. In contrast, c-ets-1 was not affected at all
under the same conditions, suggesting that an as yet unknown
factor(s), neither TIMP-1 nor TIMP-2, seems to be a serum
factor(s) responsible for the stimulation of the c-ets-1 gene
[25,29,30].
3.5. Effects of the depletion of TIMP-1 and TIMP-2 from FCS
on nuclear factors that bind to AP-1 binding site
A nuclear extract was prepared from Gin-1 cells, and the
binding of nuclear factors to a 40-bp region of the TIMP-1
gene promoter was analyzed by conducting an electropho-
retic mobility shift assay (Fig. 6). Several complexes were
detected with the wild type 40-bp oligonucleotide (W), and
these were completely competed with the non-labeled
oligonucleotide (data not shown). Complex C likely
contained cJun/cFos proteins [45] (Fig. 6b, lane 2). Complex
C formation was significantly abolished by depleting both
TIMPs from FCS (Fig. 6b, lane 4). C complex was formed
again by the re-addition of both TIMPs (Fig. 6b, lane 5).
The result that complex formation was completely
abolished by mutant oligonucleotide strongly supports theprobability that the formation of complex C was really
specific for the AP-1 motif in the promoter of the TIMP-1 gene
(Fig. 6b, lane 3).
Fig. 7. Effects of actinomycin D and puromycin on the expression of TIMP-1
gene by FCS in Gin-1 cells. Q, quiescent cells; 1 F, quiescent cells stimulated by
10% FCS for 1 h; 6 F, quiescent cells stimulated by FCS for 6 h; 1 F+5 F/AD or
5 F/PM, quiescent cells stimulated by FCS for 6 h in the presence of either
actinomycin D or puromycin during the last 5 h. Each mRNA was analyzed
by competitive RT-PCR as described in Materials and methods. Abbreviations
used in panel a are the same as those in the legend for Fig. 2a. Results are the
mean±S.D. (n=3).
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delayed-early gene
To characterize the TIMP-1 gene, we studied the effects of
both actinomycin D and puromycin, inhibitors of transcription
and protein synthesis, respectively, on the expression of this
gene in Gin-1 cells, and found that both inhibitors strongly
inhibited the expression of the gene (Fig. 7), suggesting that the
TIMP-1 gene may also be categorized as a delayed-early gene,
which was earlier shown to be the case for the TIMP-3/mig-5
gene [46]. But our result is inconsistent with that suggesting the
induction of TIMP-1 in rat neurons as an immediate-early gene
[47].
In conclusion, it had already been reported that serum
induces TIMP-1 gene expression remarkably [23–25,31], butthe identity of the factor(s) in serum had not yet been
elucidated. Also we already had shown that both TIMP-1
and TIMP-2 are constitutive components in serum [14,15].
In this study, we demonstrated that both TIMP-1 and TIMP-
2 are major serum factors that stimulated the expression of
the TIMP-1, but not TIMP-2, gene in a concentration-
dependent manner. Then what is the biological significance
of this study? We were able to demonstrate the presence of
a control mechanism to keep the TIMP-1 concentration
around 34 ng/ml in the culture medium of Gin-1 cells. Also,
as we stated in Introduction, we earlier reported that TIMP-
1 accumulates specifically in the nuclei of Gin-1 cells in a
cell cycle-dependent manner showing the maximum accu-
mulation around the S phase [21,22]. As we also previously
demonstrated immunohistochemically that nuclear TIMP-1
seems not to be bovine TIMP-1 derived from FCS in
culture medium [22,48], this study suggests that at least a
part of the TIMP-1 expressed by TIMP-1 gene activation
might be a source for trafficking of TIMP-1 to the nuclei of
cells. However, the possibility remains that TIMP-1 and
TIMP-2 function as co-factors for some component present
in the TIMP-depleted FCS that stimulates TIMP-1
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